Evidence map›Paper›PMID 29220679›Full record

Trial reportPsychiatry research2018

Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.

Oladunni Oluwoye, Katherine Hirchak, Emily Leickly, Jordan Skalisky, Sterling McPherson, Debra Srebnik, John M Roll, Richard K Ries, Michael G McDonell

Open access · bronzeAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Psychiatry research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Oladunni OluwoyeInitiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: oladunni.oluwoye@wsu.edu.
Katherine HirchakInitiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: katherine.hirchak@wsu.edu.
Emily LeicklyInitiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: emily.leickly@wsu.edu.
Jordan SkaliskyInitiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: jordan.skalisky@wsu.edu.
Sterling McPhersonElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA; Providence Medical Research Center, Providence Health Care, Spokane, WA, USA. Electronic address: smcpherson05@wsu.edu.
Debra SrebnikDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: Debra.Srebnik@kingcounty.gov.
John M RollElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: johnroll@wsu.edu.
Richard K RiesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: rries@u.washington.edu.
Michael G McDonellInitiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA, USA; Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA; Program of Excellence in Addictions Research, Washington State University, Spokane, WA, USA. Electronic address: mmcdonell@wsu.edu.
Washington State University Spokane · USUniversity of Washington · US

Funding

Novel EtG BasedContingency Management for Alcohol in the Severely Mentally IllR01AA020248 · NIAAA · WASHINGTON STATE UNIVERSITY · PI MCDONELL, MICHAEL G · 2012 to 2021
$4.6M
Contingency Management of Psychostimulant Abuse in the Severely Mentally IllR01DA022476 · NIDA · UNIVERSITY OF WASHINGTON · PI RIES, RICHARD K · 2007 to 2010
$1.9M
NIAAA NIH HHS R01 AA020248NIDA NIH HHS R01 DA022476
6 · The paper itself

Abstract

We examined whether the interaction of baseline stimulant use, assessed by urine drug tests, and type of serious mental illness (SMI) diagnosis predicted stimulant use in a trial of contingency management (CM). The interaction between baseline stimulant use and SMI diagnoses was significant in the overall sample (p=0.002) when controlling for the main effects of treatment condition, baseline stimulant use, and SMI diagnosis. Similar results were also found within the CM sample. Individuals with bipolar disorder were more or less likely, depending on their baseline stimulant-drug test results, to use stimulants during treatment compared to those with other SMI diagnoses.

Indexed as

Central Nervous System StimulantsOutcome Assessment, Health CareAdultBehavior TherapyBipolar DisorderComorbidityFemaleHumansMajor Depressive DisorderMaleMiddle AgedSchizophreniaSubstance-Related DisordersCentral Nervous System StimulantsContingency managementSerious mental illnessStimulant use

Identifiers

PMID29220679
PMCPMC5975078
OpenAlexW2770314902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.